Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Wegovy, an effective weight-loss injection, is restricted by the NHS due to high costs, limiting access for millions.
Wegovy, a weight-loss injection, helped 62-year-old Ray lose 14kg in five months, but the NHS restricts access due to high costs.
Only a fraction of the 3.4 million eligible patients in England can receive the drug, limited to two years per patient.
Introducing the drug to all eligible individuals would cost £10 billion annually, potentially bankrupting the NHS.
A second drug, Mounjaro, approved by NICE, faces similar rollout challenges to avoid overwhelming health services.
6 Articles
Wegovy, una inyección eficaz de pérdida de peso, está restringida por el NHS debido a los altos costos, limitando el acceso a millones de personas.